Learning from tragedy: safety and dosing in first-in-human trials

Alternative dosing strategies could help minimise risk for a drug’s first human recipients. Image courtesy of John Crawford (Photographer), National Cancer Institute, National Institutes of Health



  • Clinical research, National Institutes of Health, protective equipment
  • Vaccine, malaria, injection, dose, dosage
  • Bial, Portugal
  • Clinical research, researcher, test tubes, AZT, HIV